NCT00130494View on ClinicalTrials.gov

Zoledronic Acid Administration to Metastatic Breast Cancer Patients With Non-symptomatic Bone Lesions

PHASE3TerminatedINTERVENTIONAL
Enrollment

97

Participants

Timeline

Start Date

August 29, 2002

Primary Completion Date

November 20, 2006

Study Completion Date

October 22, 2007

Conditions
Breast CancerNeoplasm Metastasis
Interventions
DRUG

Zoledronic acid

Trial Locations (1)

28700

Spanish Breast Cancer Research Group (GEICAM), San Sebastián de los Reyes

Sponsors

Collaborators (1)

Novartis
All Listed Sponsors
collaborator

Novartis

INDUSTRY

lead

Spanish Breast Cancer Research Group

OTHER